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The transcription factor cAMP response element (CRE)-binding
protein (CREB) has been shown to regulate neural plasticity. Drugs
of abuse activate CREB in the nucleus accumbens, an important
part of the brain’s reward pathways, and local manipulations of
CREB activity have been shown to affect cocaine reward, suggest-
ing an active role of CREB in adaptive processes that follow
exposure to drugs of abuse. Using CRE-LacZ reporter mice, we
show that not only rewarding stimuli such as morphine, but also
aversive stimuli such as stress, activate CRE-mediated transcription
in the nucleus accumbens shell. Using viral-mediated gene transfer
to locally alter the activity of CREB, we show that this manipulation
affects morphine reward, as well as the preference for sucrose, a
more natural reward. We then show that local changes in CREB
activity induce a more general syndrome, by altering reactions to
anxiogenic, aversive, and nociceptive stimuli as well. Increased
CREB activity in the nucleus accumbens shell decreases an animal’s
responses to each of these stimuli, whereas decreased CREB activ-
ity induces an opposite phenotype. These results show that envi-
ronmental stimuli regulate CRE-mediated transcription within the
nucleus accumbens shell, and that changes in CREB activity within
this brain area subsequently alter gating between emotional
stimuli and their behavioral responses. This control appears to be
independent of the intrinsic appetitive or aversive value of the
stimulus. The potential relevance of these data to addiction and
mood disorders is discussed.
Transcription factors, by regulating protein expression, par-ticipate in neural plasticity and adaptation. Stimuli that
change transcriptional activity in a brain structure may alter over
time the way information is processed by that structure. At more
integrated levels, this plasticity can lead to changes in the
interaction between an individual and its environment. Exam-
ples include learning processes, and changes in perception,
interpretation, and behavioral responses to environmental stim-
uli. The cAMP response element (CRE)-binding protein,
CREB, is a constitutively expressed transcription factor acti-
vated by phosphorylation through the cAMP pathway and other
intracellular signaling cascades (1). Within the central nervous
system, CREB has been associated with learning and memory
(2–6), as well as with molecular and behavioral changes induced
by antidepressants (7, 8) and drugs of abuse (9–15). In these
latter cases, changes in second messenger pathways activating
CREB (7, 9), changes in CREB levels (12), and changes in
CRE-mediated transcription (8, 15) have been observed in
several discrete brain areas.
The nucleus accumbens, a forebrain structure critical for
reward and motivation (16–23), has a key role in reinforcing
properties of drugs of abuse (12, 17–21). Chronic exposure to
cocaine or to several other drugs of abuse increases cAMP levels
and cAMP-dependent protein kinase (PKA) activity in the
nucleus accumbens (9, 12). These adaptations cause sustained
activation of CREB. Stimulation of PKA (24), or CREB (13, 14)
overexpression, in the nucleus accumbens reduces the rewarding
effects of cocaine, suggesting that activation of this pathway
might counteract positive feedback adaptations that tend to
intensify drug reward (25, 26).
In the present study, we used viral-mediated gene transfer to
manipulate CREB within the nucleus accumbens. Our aim was
to understand the behavioral consequences of sustained local
changes in CREB activity. Microinjections of a herpes simplex
virus (HSV) vector (13, 14) allowed us to overexpress either
CREB itself or the dominant negative mutant mCREB, in which
mutation of Ser-133 to alanine prevents its own activation and
renders it an inhibitor of endogenous CREB (27). Using these
molecular tools, we show that CREB overexpression in the
nucleus accumbens shell reduces the rewarding actions of mor-
phine and sucrose, whereas mCREB expression has the opposite
effect. We also found, using CRE-LacZ reporter mice, that
CRE-mediated transcription in the nucleus accumbens is acti-
vated not only by drugs of abuse, but also by aversive stimuli.
Based on this observation, we studied a possible role for CREB
in regulating responses to several types of aversive conditions,
including anxiogenic and nociceptive stimuli. Our data show that
CREB overexpression reduces sensitivity to these stimuli,
whereas mCREB expression increases it.
We conclude that levels of CREB activity in the nucleus
accumbens shell can be regulated by environmental stimuli, and
are a key regulator of behavioral responses to emotional stimuli.
This control appears to be independent of the intrinsic appetitive
or aversive value of the stimulus.
Materials and Methods
Animals. Two lines of CRE-LacZ mice with a reporter gene
expressing the -galactosidase (-gal) under the control of
CREs were used. One line, previously described (3), has low
basal expression of the transgene; the second line has higher
basal expression. The construct of this second line, which
contains seven CRE-consensus sequences in tandem upstream
of a minimum promoter and the -gal gene, is f lanked by
insulator sequences from the chicken -globulin gene. Male
Sprague–Dawley rats (Charles River Breeding Laboratories),
initially weighing 250–275 g, were acclimatized to housing
conditions for 1 week before starting the experiments. Proce-
dures were approved by local animal care and use committees.
Stereotaxic Surgery. Surgery was performed as described (13).
Bilateral injections (1.5 l) of HSV vectors were delivered over
7.5 min into the nucleus accumbens shell (relative to bregma: rat,
AP  1.9, Lat  2.4, DV  6.7 mm below dura, with a 10°
lateral angle; mouse, AP  1.7, Lat  2.3, DV  4.7 mm
below skull, with a 20° lateral angle). Injection placements were
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checked at the end of the experiments. The injected viruses were:
HSV-LacZ, coding for the control protein -gal; HSV-CREB;
HSV-mCREB; or HSV-CreGFP, coding a bacteriophage Cre
recombinase-GFP fusion protein.
CRE-Mediated Transcription. As described (15), 25-mg morphine
pellets were implanted on day 1 and day 3 in mice from the
CRE-LacZ line with low basal expression (3). Mice were per-
fused on day 6. Mice from the same line were subjected to
different stress conditions and perfused 4 h after the start of the
stress. The unpredictable foot-shock procedure consisted of 120
shocks (0.3 mA, 5 s duration), delivered through a metallic rod
floor at random intervals over 1 h. The restraint stress lasted 1 h,
during which mice were placed in a cylinder (2.8 cm diameter, 11
cm long, 0.6 cm hole at the end). The social stress involved
placing the mice for 4 h in a cage of 5 C57BL6J mice that had
been housed together for 2 weeks. A group of mice was also
subjected to 5 days of repeated unpredictable stress similar to
that described elsewhere (28); they were perfused 4 h after the
start of the last stress (a 1-hr restraint procedure). To test the
influence of HSV vectors on CRE-mediated transcription, we
used the CRE-LacZ line with higher basal expression. Those
mice were subjected to the foot-shock procedure before perfu-
sion. Cells overexpressing CREB or expressing mCREB were
detected using an antibody recognizing both proteins (see be-
low), and double staining was used to quantify the percentage of
infected cells that also expressed high levels of -gal.
Immunostaining. Perfusion of the animals, cutting of the brains
(40-m sections), and immunostaining were done using standard
procedures (15). CREB (1:200, Upstate Biotechnology, Lake
Placid, NY) and -gal (1:500, 5 Prime 3 3 Prime) immuno-
staining was assessed with rabbit antisera; DARPP-32 (1:10,000,
gift from P. Greengard, Rockefeller University, New York) and
GFAP (glial fibrillary acidic protein, 1:1,000, Chemicon) immu-
nostaining was assessed with mouse antibodies. We used a goat
anti--gal antibody (1:5,000, Biogenesis, Brentwood, NH) for
CREB-gal double staining. Because the CREB antibody was
not directed against the part of the protein that is mutated in
mCREB, it was also used to detect cells expressing high levels of
mCREB. Secondary antibodies were Cy2 or Cy3 conjugated
(1:200, Jackson ImmunoResearch). One section every 200 m
was processed.
Time Course of the Transgene Expression. Rats were perfused at
different time points after HSV-LacZ injection (3, 6, or 12 h; 1,
2, 3, 4, 5, or 6 days). -gal expressing cells were assessed by X-Gal
assay and counted bilaterally on 40-m sections. One section was
counted every 200 m over the entire extent of the nucleus
accumbens.
Place Conditioning. Conditioned place preference to morphine
sulfate (concentrations expressed as base) and place aversion to
naloxone-HCl were conducted in independent experiments,
using a previously described procedure (13). Before viral injec-
tions, rats freely explored the apparatus for 30 min. On days 3
and 4 postinjection, they first received saline (1 mlkg, s.c.) and
were confined to one side compartment of the apparatus for 1 h;
3 h later, they received the drug (s.c.) and were confined to the
other side compartment for 1 h. On day 5, they explored the
entire apparatus for 30 min, and the time spent in each com-
partment was recorded. Place conditioning was calculated as the
difference in time spent on the drug-paired side vs. the saline-
paired side.
Sucrose Preference. Rats were habituated to drink a 1% sucrose
solution for 3 days, then went through a two bottles choice
procedure. Four days later, the HSV vectors were injected and
3 days thereafter the rats were tested. The experiments started
at 7 p.m., when lights turned off in the animal room, and were
conducted under red light. Two hours before each test, the rats
were individually housed with access to food. At 7 p.m., they
were given access to the two bottles, and their f luid intake was
measured over 30 min.
Anxiety-Related Behaviors. In the first experiment, 3 days after
viral injection, we tested for 5 min the time spent in the open and
closed arms of an elevated plus-maze (1 m from the floor, 12
cm 50 cm arms). In two other independent experiments, 4 days
after viral injection, we tested the locomotor activity as well
as the time in the center (20 cm square) and in the borders
of a 75-cm square open-field, using a video-tracking system
(Ethovision, Noldus Information Technology, Wageningen, The
Netherlands). One experiment was conducted under dim light
(3 lx), and the second under brighter light (250 lx). Under 250
lx, HSV-mCREB rats showed an initial freezing when placed in
the center of the open-field. To avoid confounding data related
to this initial freezing, the analysis of the behavior started 1 min
after placing the rat in the center. The behavior was studied for
the next 10 min.
Response to Nociceptive Stimuli. The threshold sensitivity to foot
shocks and the paw licking latency on a hot plate were deter-
mined in independent experiments. In the first procedure, after
2 min of habituation the rats received a foot shock every 30 s
starting at 0.05 mA with a 0.05-mA increment between each
shock. The first appearance of a flinch, an audible vocalization,
and a jump were recorded. In the second experiment, we
measured the paw licking latency on a 52°C hot plate. A 20-s
cut-off time was used to prevent tissue damage.
Statistics. Analysis of variance was used to study differences
between the groups (independent variables), and to compare
pretest to test data (dependent variables). The Duncan test was
used for post hoc comparisons. A t test was used for all other
analysis implicating only a two-groups comparison.
Results
Response to Rewarding Stimuli. CREB manipulations within the
nucleus accumbens shell alter morphine reward in a place-
conditioning protocol (F3,155  9.16, P  0.0001; Fig. 1a). In
control groups (sham-operated and HSV-LacZ rats), morphine
place preference first occurred for 0.5 mgkg (P  0.02 in both
cases), suggesting that viral infection per se did not alter mor-
phine place-conditioning. Local CREB overexpression reduced
the sensitivity to morphine (P 0.01 preference for 1 mgkg; no
preference at lower doses), whereas mCREB expression in-
creased it (P  0.015 preference for all doses).
To generalize these findings to a natural reward, and to a
paradigm free of associative memory, we studied sucrose pref-
erence (Fig. 1b). CREB manipulations did not affect the total
amount of liquid the rats drank (F3,53  0.21, P0.88), but did
affect their choice between water and sucrose (F3,53  6.99, P 
0.001). Control groups showed similar sucrose preference;
CREB overexpression decreased this preference (P  0.025
against controls), whereas mCREB expression increased it (P 
0.05 against control and HSV-CREB groups).
Validation of the Approach. Using mice from the high-expression
CRE-LacZ line, we show that viral-mediated CREB over-
expression increases CRE-mediated transcription in the nu-
cleus accumbens shell, whereas mCREB expression decreases it
(F2,11 24.4, P 0.001; controls differ from other groups at P
0.025), confirming the expected functional effects of these viral
vectors on CREB activity (Fig. 2a). The behavioral experiments
were performed within the time-window of viral-mediated gene
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expression, as shown using HSV-LacZ (Fig. 2b). Transgene
expression was apparent within hours postinjection and largely
dissipated by day 6. Consistent with this time course, CREB
manipulation had no effect on sucrose preference when animals
were studied 18 days after viral injection (F3,29  0.13, P  0.9;
data not shown), at which time transgene expression is no longer
detectable. We also confirmed that HSV vectors are neurotropic
(Fig. 2 g–m). A large majority of infected cells in nucleus
accumbens shell expressed DARPP-32 (dopamine- and cAMP-
regulated phosphoprotein of 32 kDa), a marker for medium
spiny neurons that predominate in this brain area. In contrast, no
infected cell stained positively for GFAP (glial fibrillary acidic
protein), a marker for astroglia.
CRE-Mediated Transcription. Both rewards (17–22, 29–31) and
stress (30–32) stimulate dopamine transmission, which is up-
stream of CREB, in the nucleus accumbens. In this brain area,
c-Fos, an identified target gene of CREB (1, 10), is also induced
in response to both rewards (30) and stress (30). We show here
that chronic morphine increased CRE-mediated transcription in
the nucleus accumbens (shell: P  0.003; core: P  0.005; Fig.
3). Stress also increased CRE activity in the nucleus accumbens
shell and to a lesser extent in the core (Fig. 3). This increase was
observed after intermittent inescapable foot shocks (shell: P 
0.002; core: P 0.03; shell core, F1,6 37.17, P 0.001). The
increase was also observed after restraint stress (shell: P 0.008;
core: P  0.003; shell  core, F1,6  12.83, P  0.02), as well as
after a more natural stress—namely, the social stress of being
introduced into an unfamiliar group of animals (shell: P 0.009;
core: P  0.02; shell  core, F1,6  14.14, P  0.01). No
significant induction of CRE activity was observed in dorsal
striatum (data not shown). A course of repeated unpredictable
stress also increased CRE activity (shell: P  0.007; core: P 
0.002; data not shown).
Anxiety-Related Behaviors. Increased CRE-mediated transcrip-
tion by stress suggested that CREB activity within the nucleus
accumbens might have broader influence than simply modulat-
ing reward sensitivity. To evaluate this possibility, we first tested
whether CREB manipulation influences behavior in anxiogenic
situations. mCREB expression increased anxiety-related behav-
iors in the elevated plus-maze (Fig. 4a), HSV-mCREB rats
spending less time in the open arms of the apparatus (F3,28 
3.87, P 0.02; mCREB different from other groups at P 0.05).
This finding was confirmed by measuring the time spent in the
center of an open-field under bright light (F3,37 3.84, P 0.02;
Fig. 4b Left). A comparison between bright and dim light
conditions showed that brighter light did not affect the time
HSV-CREB rats spent in the center (P  0.75), but reduced it
Fig. 1. Response to rewarding stimuli. (a) Morphine place preference after
sham surgery (n 10–18), or expression of LacZ (n 7–10), mCREB (n 5–11),
or CREB (n  6–13). Four morphine doses were tested (indicated in mgml
under the Sham bar graph). CREB overexpression reduced the sensitivity to
morphine, whereas mCREB expression increased it. (b) Sucrose preference.
Sham surgery (n  14) or -gal expression (n  15) did not affect the sucrose
preference; CREB overexpression (n 16) reduced it, whereas mCREB expres-
sion (n  12) increased it. Data are presented as difference in liquid intake
between the two bottles (sucrose vs. water), or as sucrose intake in percentage
of the total fluid intake (Lower Right). CREB manipulation did not affect the
total fluid intake (Upper Right).
Fig. 2. Viral-mediated gene transfer. (a) In CRE-LacZ reporter mice, the
proportion of infected cells expressing -gal is increased with CREB overex-
pression (n 5) and decreased by mCREB expression (n 5), as compared with
cells infected by a control virus expressing a GFP fusion protein (n4). (b) Time
course of transgene expression determined in rats by using HSV-LacZ (n 5–8
accumbens). (c) Bilateral injection of HSV-LacZ in the nucleus accumbens shell
revealed by X-Gal assay. (d) Higher magnification showing that the infection
is restricted to the shell and does not diffuse to the core (ac, anterior com-
missure; Co, core; Sh, shell). (e and f ) CREB immunoreactivity in the nucleus
accumbens shell in a control (e) or in an HSV-CREB ( f) injected side. (g–m) The
majority of the infected cells are medium spiny neurons, as shown by -gal
positive processes of HSV-LacZ infected cells (g), and by the colocalization of
-gal (h) with DARPP-32 (i) (merged confocal image in j). No colocalization of
-gal (k) and GFAP (l) was observed (merged confocal image in m).









for both controls (P  0.05) and HSV-mCREB rats (P  0.001)
(Fig. 4c), this effect being stronger with HSV-mCREB than in
controls (F1,35 4.64, P 0.04). Lastly, manipulations of CREB
activity had no influence on the time spent in the center of the
test at 3 lx (F2,19  0.25, P  0.75; Fig. 4c) or on the total
locomotor activity under either 3 lx (F2,19  1.71, P  0.2; data
not shown) or 250 lx (F3,37  1.84, P  0.15) (Fig. 4b Right).
Aversive and Nociceptive Responses. Our findings thus far show
that CREB overexpression in the nucleus accumbens shell
decreases an animal’s responses both to rewarding stimuli and to
certain anxiogenic situations, whereas mCREB expression has
the opposite effects. This suggested that local CREB activity
could control the stimulus intensity necessary to elicit a behav-
ioral response independent of the emotional valence (reward vs.
aversion) of the stimulus. To test this hypothesis, we studied the
influence of CREB on the sensitivity to an aversive stimulus,
naloxone (Fig. 5 a and b). We first confirmed that a place
aversion for naloxone in morphine-naive rats could readily be
observed (data not shown). Then, we found that CREB over-
expression reduced the sensitivity to naloxone, whereas mCREB
expression increased it. In control groups, naloxone aversion
appeared at 0.25 mgkg (P  0.05 in both cases). The only dose
inducing significant aversion after CREB overexpression was 5
mgkg (P  0.01), whereas HSV-mCREB rats showed an
aversion at all of the doses tested (P  0.05 for all doses).
We next tested the influence of CREB on the unconditioned
behavioral responses to nociceptive stimuli. Local manipulation
Fig. 3. CRE-mediated transcription. In CRE-LacZ mice, chronic morphine
(n 3, Top Right) increases the density of-gal positive neurons in the nucleus
accumbens as compared with sham-operated mice (n  4, Top Left). Foot
shocks (n  3, Middle Right), restraint stress (n  3, Bottom Left), and social
stress (n  3, Bottom Right) also increase CRE-mediated transcription as
compared with controls (n5, Middle Left). ac, anterior commissure; Co, core;
Sh, shell.
Fig. 4. Anxiety-related behaviors. (a) In the elevated plus-maze, local mCREB expression reduces the time spent in the open-arms (n 7–8). (b) In the open-field
(250 lx), similar results were obtained with the time spent in the center of the test (Left; n 8–12). No influence of CREB was observed on the locomotor activity
of the same rats (Right). (c) Comparison between the 250-lx illumination and a less anxiogenic condition (3 lx; n 6–9) shows that higher illumination reduces
the time spent in the center of the test. This anxiogenic effect of light intensity disappears with CREB overexpression, and is enhanced with mCREB expression.
Fig. 5. Response to aversive and nociceptive stimuli. (a) Naloxone place
aversion after sham surgery (n 12–18), or expression of mCREB (n 6–10) or
CREB (n  5–8) in the nucleus accumbens shell. Four naloxone doses were
tested (indicated in mgml above the Sham bar graph). CREB overexpression
reduced naloxone aversion, whereas mCREB expression increased it. (b) HSV-
LacZ group (n 6–7) had the same aversion threshold as the Sham group. Rats
overexpressing CREB (n 6) show naloxone aversion only when exposed to a
high dose (5 mgkg). (c) HSV-mCREB rats (n  9) vocalized and jumped in
response to lower foot-shock intensities than HSV-CREB rats (n 9); interme-
diate jumping threshold was seen in control groups (n  6–8). (d) The paw
licking latency on a hot plate is shorter in HSV-mCREB rats (n  11) than
in HSV-CREB rats (n  12). Control groups showed intermediate latencies
(n  9–14).
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of CREB changed the threshold foot-shock intensities required
to elicit vocalization (F3,28  3.09, P  0.05) or jumping (F3,28 
15.18, P  0.001), without significantly affecting the threshold
intensity eliciting a flinch reaction (F3,28  1.45, P  0.24; Fig.
5c). Rats expressing mCREB vocalized and jumped at lower
intensities than rats overexpressing CREB (P  0.02 and P 
0.001, respectively); intermediate threshold intensities for jump-
ing were seen in control groups (P  0.04 in each case). We
confirmed the influence of CREB activity on nociception with
another test, which measures paw licking latency on a hot plate
(F3,42  5.95, P  0.002) (Fig. 5d). This latency was shorter in
HSV-mCREB rats than in HSV-CREB rats (P 0.001), with the
control groups showing intermediate latencies (P  0.05 in each
case).
Discussion
We show that localized changes in a transcription factor can have
broad functional consequences, affecting interactions between
an individual and its environment. By overexpressing CREB in
the nucleus accumbens shell, we decreased responses to appet-
itive and aversive stimuli, and we obtained opposite effects with
the dominant negative mutant mCREB.
Recent (15) and present data show that chronic morphine
stimulates CRE-mediated transcription in the nucleus accum-
bens. Because overexpression of CREB in this brain area
decreases morphine reward, this suggests that sustained CREB
activation in the nucleus accumbens could be a mechanism by
which drugs of abuse produce tolerance to their rewarding
effects. A similar phenomenon was observed with cocaine (9,
12–14). We also show that the influence of CREB can be
extended to natural rewards, such as sucrose. Interestingly, a loss
of interest in natural rewards, to the gain of drug-directed
behaviors, is one of the clinical symptoms defining addiction
(33). Our data suggest that elevated CREB activity in the
nucleus accumbens could be one of the molecular mechanisms
underlying this reduction in the rewarding value of natural
stimuli after drug treatment. It should however be emphasized
that chronic drug intake has been associated not only with
tolerance mechanisms, but also with sensitization, in particular
of drug-seeking behaviors (26, 34). Our data show that CREB
activity in the nucleus accumbens is unlikely to be the molecular
switch of the sensitization mechanisms, which might involve
other transcription factors (35, 36) or other brain areas.
Mutant mice partly deficient in CREB show enhanced cocaine
preference, consistent with our findings, but show reduced
morphine preference, which is not consistent (37). However,
CREB is knocked down in the entire brain and other tissues of
these mice, beginning at the earliest developmental periods. An
advantage of the approach used in the present study is the
temporal and anatomical specificity allowed by viral vectors. Our
data indicate that the morphine phenotype of these mice may be
related either to brain areas other than the nucleus accumbens
or to developmental adaptations.
We also show here that stress, like drugs of abuse, activates
CRE-mediated transcription in the nucleus accumbens. Thus,
this transcriptional response appears to be independent of the
valence of the stimulus. The functional significance of nucleus
accumbens regulation by aversive stimuli is less understood than
its regulation by rewards (17–23). Dopamine transmission in the
nucleus accumbens has been proposed to control motivational
rather than hedonic responses (26, 38); it might also be involved
in the development of emotional memory to both appetitive and
aversive stimuli (39, 40). Based on this literature, we chose to
further analyze CREB’s influence in this brain region, by
considering not only how it affects reward, but also how it affects
responses to anxiogenic, aversive, and nociceptive stimuli. The
data show that the behavioral consequences of CREB manip-
ulation in the nucleus accumbens, like the activation of CREB
seen in this region, are independent of the valence of the
stimulus.
Recent attention has been given to the influence of the
nucleus accumbens in nociceptive responses (41–43). We show
here that CREB activity in the nucleus accumbens shell partic-
ipates in setting the nociceptive threshold. The neuroanatomical
basis for this influence is not yet fully understood, but the nucleus
accumbens does receive direct afferents from spinal cord neu-
rons (44). It also receives inputs from or sends projections to
several structures (45) that are involved in nociceptive responses,
including periaqueductal gray, VTA, habenula, lateral hypothal-
amus, and amygdala. We show here that local CREB activity
affects an animal’s sensitivity to environmental changes, such as
brighter light, which make a situation more anxiogenic, an effect
that could be related to inputs from the bed nucleus of the stria
terminalis (45), which is proposed to control anxiety (46). Lastly,
CREB manipulation produced a robust change in sensitivity to
the aversive properties of naloxone. CREB overexpression de-
creased naloxone aversion, just as it decreased cocaine (13, 14),
morphine, and sucrose reward. This indicates that the nucleus
accumbens shell could play a critical role in the interaction
between endogenous opioid tone, revealed by naloxone, and the
hedonic state of the animal. It should be noted that CREB
manipulation in the nucleus accumbens did not affect locomotor
activity, similar to previous observations (14). This suggests that
CREB’s influence on behavioral responses may be restricted to
stimuli with a strong emotional component. The striatal complex
is thought to be a key structure controlling sensorimotor gating.
This interface function of the dorsal striatum has been extended
to the more limbic nucleus accumbens, which is proposed to
serve as an interface between motivation and action (16). Our
data, showing a general influence of the nucleus accumbens on
behavioral responses to emotional stimuli, independent of their
valence, support such an interface role and extend it to a wide
range of situations. We propose that one of the functions of the
nucleus accumbens shell might be to gate behavioral responses
to emotional stimuli by controlling the stimulus intensity nec-
essary to produce the appropriate behavioral expression of the
emotion, a function that CREB activity can locally influence.
A possible role for the nucleus accumbens in the symptom-
atology of mood disorders is not surprising considering its role
in motivation and responses to hedonic stimuli (16–23), both of
which are severely affected in mood disorders (33, 47). Indeed,
abnormalities in the activity and morphology of nucleus accum-
bens neurons have been observed in depressed patients (48). We
show here that inescapable foot shocks, following a protocol
which induces ‘‘learned helplessness,’’ as well as other forms of
stress, activate CRE-mediated transcription in the nucleus ac-
cumbens. The forced swim test, a procedure used to screen
antidepressants (49), was also previously shown to increase
CREB phosphorylation in the same brain area (14). The de-
creased rewarding effects of cocaine after CREB overexpression
in the nucleus accumbens led to our earlier proposal that CREB
hyperactivity in this region might induce an anhedonia-like state,
or even dysphoria (13, 14). The results shown here with mor-
phine and sucrose are consistent with this hypothesis. However,
when studying an aversive stimulus, such as naloxone, we ob-
served that HSV-CREB decreased the aversion, instead of
increasing it, as would have been expected from a simple
dysphoric state. Moreover, when studying anxiogenic situations,
we found that local expression of mCREB, not CREB, is
associated with increased anxiety-like behavior. While our new
data confirm CREB’s influence in reducing responses to re-
warding stimuli, they also suggest a more complex behavioral
effect of CREB activity in the nucleus accumbens than we had
previously hypothesized. Thus, we have reconsidered our data in
light of the gating function attributed to the striatal complex and
nucleus accumbens (16), and suggest that CREB hyperactivity









might locally inhibit this function. This would explain why
responses to both rewarding and aversive stimuli are similarly
reduced on CREB overexpression in this brain region. This
hypothesis is consistent with recent data obtained in the forced
swim test (14), where we showed that CREB overexpression in
the nucleus accumbens decreases struggling behavior in re-
sponse to swim stress. Together, these findings raise the possi-
bility that increased CREB activity in the nucleus accumbens
shell may contribute to certain symptoms associated with de-
pression and other mood disorders (33, 47), such as anhedonia
and decreased emotional reactivity. For example, severe (mel-
ancholic) depression is characterized by reduced emotional
reactivity, and lower sensitivity to exogenous nociceptive stimuli
has been observed in depressed patients (50). Also, a general
deficit in responses to emotional stimuli has been observed in
posttraumatic stress disorder (33, 51). However, we must em-
phasize that a localized molecular change, such as activation of
CREB in the nucleus accumbens, cannot by itself mimic or
explain complex syndromes like depression or any other mood
disorder. Many additional brain areas and molecular mecha-
nisms are certainly involved.
Results of the present study also raise the question of the
molecular changes, downstream of CREB, responsible for the
behavioral adaptations observed. As a transcription factor,
CREB itself is unlikely to be the molecule acutely gating
information; the time frame of its action is far too slow. Rather,
CREB function is more likely adaptive: modification of CREB
activity induces protein expression changes that then alter
neuronal responses to subsequent stimuli. Dynorphin is one of
CREB’s target genes in the nucleus accumbens (13). Previous
work showed that dynorphin, released from nucleus accumbens
neurons, locally inhibits dopamine transmission. Moreover,
dynorphin induction can account for some of the behavioral
changes seen on CREB manipulation (13, 14). However, it is
likely that other neurotransmitter systems and the expression of
many other genes are also affected by changes in CREB func-
tion. In vitro studies and analysis of promoter sequences have led
to a list of potential target genes (1), including other neuropep-
tides, receptors, and signal transduction molecules, although
their actual regulation by CREB in the nucleus accumbens
remains to be proved. The search for target genes is further
complicated by the fact that some of them, such as c-Fos (1, 10),
are themselves transcription factors that also affect gene expres-
sion. A genome-wide analysis would be useful to more fully
understand the molecular changes that occur in the nucleus
accumbens when CREB activity is locally affected.
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